title: What are the prospects for controlling hepatitis C?
authors.affiliation: Peter Medawar Building for Pathogen Research and National Institute for Health Research Biomedical Research Centre, University of Oxford, Oxford, United Kingdom. Paul.klenerman@ndm.ox.ac.uk
authors.forename: Paul
authors.initials: P
authors.lastname: Klenerman
authors.forename: Vicki
authors.initials: V
authors.lastname: Fleming
authors.forename: Ellie
authors.initials: E
authors.lastname: Barnes
mesh_terms: D014644:Genetic Variation; D016679:Genome, Viral; D014943:Global Health; D016174:Hepacivirus / Q000235:genetics* / Q000276:immunology* / Q000302:isolation & purification; D006509:Hepatitis B / Q000175:diagnosis / Q000517:prevention & control / Q000821:virology; D017325:Hepatitis B Vaccines / Q000235:genetics / Q000276:immunology* / Q000627:therapeutic use; D006515:Hepatitis B virus / Q000235:genetics / Q000276:immunology / Q000302:isolation & purification; D006526:Hepatitis C / Q000175:diagnosis / Q000517:prevention & control* / Q000821:virology; D006801:Humans; D012367:RNA, Viral / Q000235:genetics / Q000302:isolation & purification*
chemical_list: D017325:Hepatitis B Vaccines; D012367:RNA, Viral